Abstract
Although there is a continually growing number of patients with congenital heart disease (CHD) due to medical and surgical advances, these patients still have a poorer prognosis compared to healthy individuals of similar age. In patients with heart failure, microvascular dysfunction (MVD) has recently emerged as a crucial modulator of disease initiation and progression. Because of the substantial pathophysiological overlap between CHD and heart failure induced by other etiologies, MVD could be important in the pathophysiology of CHD as well. MVD is believed to be a systemic disease and may be manifested in several vascular beds. This review will focus on what is currently known about MVD in the peripheral vasculature in CHD. Therefore, a search on the direct assessment of the vasodilatory capacity of the peripheral microcirculation in patients with CHD was conducted in the PubMed database. Since there is little data available and the reported studies are also very heterogeneous, peripheral MVD in CHD is not sufficiently understood to date. Its exact extent and pathophysiological relevance remain to be elucidated in further research.
[1]
Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990-2017. Medicine (Baltimore) 2020; 99(23): e20593.
[2]
Moutafi AC, Alissafi T, Chamakou A, et al. Neurohormonal activity and vascular properties late after aortic coarctation repair. Int J Cardiol 2012; 159(3): 211-6.
[http://dx.doi.org/10.1016/j.ijcard.2011.02.071] [PMID: 21429604]
[http://dx.doi.org/10.1016/j.ijcard.2011.02.071] [PMID: 21429604]
[3]
Nasir-Ahmad S, Cordina R, Liew G, McCluskey P, Celermajer D. The eye in CHD. Cardiol Young 2018; 28(8): 981-5.
[4]
Vanreusel I, Segers VFM, Craenenbroeck EV, Berendoncks AV. Coronary microvascular dysfunction in patients with congenital heart disease. Curr Cardiol Rev 2023; 19(4): e190123212886.
[http://dx.doi.org/10.2174/1573403X19666230119112634] [PMID: 36658708]
[http://dx.doi.org/10.2174/1573403X19666230119112634] [PMID: 36658708]
[5]
Vilela MA, Sbruzzi G, Pellanda LC. Prevalence of ophthalmological abnormalities in children and adolescents with CHD: systematic review and meta-analysis of observational studies. Cardiol Young 2016; 26(3): 477-84.
[http://dx.doi.org/10.1016/j.ijcard.2010.08.030] [PMID: 20840883]
[http://dx.doi.org/10.1016/j.ijcard.2010.08.030] [PMID: 20840883]
[6]
Marino P, de Oliveira Lopes G, Borges PJ, Cola CTM, Kopiler AD, Tibirica E. Evaluation of systemic microvascular reactivity in adults with congenital heart disease. Congenit Heart Dis 2018; 13(6): 978-87.
[http://dx.doi.org/10.1111/chd.12660] [PMID: 30203466]
[http://dx.doi.org/10.1111/chd.12660] [PMID: 30203466]
[7]
Zomer AC, Vaartjes I, Uiterwaal CSPM, et al. Circumstances of death in adult congenital heart disease. Int J Cardiol 2012; 154(2): 168-72.
[http://dx.doi.org/10.1016/j.ijcard.2010.09.015] [PMID: 20934226]
[http://dx.doi.org/10.1016/j.ijcard.2010.09.015] [PMID: 20934226]
[8]
Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 2018; 39(37): 3439-50.
[http://dx.doi.org/10.1093/eurheartj/ehy531] [PMID: 30165580]
[http://dx.doi.org/10.1093/eurheartj/ehy531] [PMID: 30165580]
[9]
Bilak JM, Alam U, Miller CA, McCann GP, Arnold JR, Kanagala P. Microvascular dysfunction in heart failure with preserved ejection fraction: Pathophysiology, assessment, prevalence and prognosis. Card Fail Rev 2022; 8: e24.
[http://dx.doi.org/10.15420/cfr.2022.12] [PMID: 35846985]
[http://dx.doi.org/10.15420/cfr.2022.12] [PMID: 35846985]
[10]
Premer C, Kanelidis AJ, Hare JM, Schulman IH. Rethinking endothelial dysfunction as a crucial target in fighting heart failure. Mayo Clin Proc Innov Qual Outcomes 2019; 3(1): 1-13.
[http://dx.doi.org/10.1016/j.mayocpiqo.2018.12.006] [PMID: 30899903]
[http://dx.doi.org/10.1016/j.mayocpiqo.2018.12.006] [PMID: 30899903]
[11]
Hanssen H, Streese L, Vilser W. Retinal vessel diameters and function in cardiovascular risk and disease. Prog Retin Eye Res 2022; 91: 101095.
[http://dx.doi.org/10.1016/j.preteyeres.2022.101095] [PMID: 35760749]
[http://dx.doi.org/10.1016/j.preteyeres.2022.101095] [PMID: 35760749]
[12]
Flammer AJ, Anderson T, Celermajer DS, et al. The assessment of endothelial function: From research into clinical practice. Circulation 2012; 126(6): 753-67.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.093245] [PMID: 22869857]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.093245] [PMID: 22869857]
[13]
Maruhashi T, Kihara Y, Higashi Y. Assessment of endothelium-independent vasodilation. J Hypertens 2018; 36(7): 1460-7.
[http://dx.doi.org/10.1097/HJH.0000000000001750] [PMID: 29664811 ]
[http://dx.doi.org/10.1097/HJH.0000000000001750] [PMID: 29664811 ]
[14]
Deshpande SR, Pai KV, Satyanarayana K, Rao MNA. Nitric oxide modulators: An emerging class of medicinal agents. Indian J Pharm Sci 2012; 74(6): 487-97.
[http://dx.doi.org/10.4103/0250-474X.110572] [PMID: 23798773]
[http://dx.doi.org/10.4103/0250-474X.110572] [PMID: 23798773]
[15]
Vanreusel I, Taeymans J, Van Craenenbroeck E, Segers VFM, Van Berendoncks A, Briedé JJ, et al. Elevated oxidative stress in patients with congenital heart disease and the effect of cyanosis: a meta-analysis. Free Radic Res 2023; 57(6-12): 470-86.
[16]
Goldstein BH, Golbus JR, Sandelin AM, et al. Usefulness of peripheral vascular function to predict functional health status in patients with Fontan circulation. Am J Cardiol 2011; 108(3): 428-34.
[http://dx.doi.org/10.1016/j.amjcard.2011.03.064] [PMID: 21600541]
[http://dx.doi.org/10.1016/j.amjcard.2011.03.064] [PMID: 21600541]
[17]
Goldstein BH, Urbina EM, Khoury PR, et al. Endothelial function and arterial stiffness relate to functional outcomes in adolescent and young adult fontan survivors. J Am Heart Assoc 2016; 5(9): e004258.
[http://dx.doi.org/10.1161/JAHA.116.004258] [PMID: 27664807]
[http://dx.doi.org/10.1161/JAHA.116.004258] [PMID: 27664807]
[18]
Lambert E, d’Udekem Y, Cheung M, et al. Sympathetic and vascular dysfunction in adult patients with Fontan circulation. Int J Cardiol 2013; 167(4): 1333-8.
[http://dx.doi.org/10.1016/j.ijcard.2012.04.015] [PMID: 22525342]
[http://dx.doi.org/10.1016/j.ijcard.2012.04.015] [PMID: 22525342]
[19]
Nakamura M, Yoshida H, Arakawa N, Mizunuma Y, Makita S, Hiramori K. Endothelium-dependent vasodilatation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease. Eur Heart J 1996; 17(12): 1875-81.
[http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a014806] [PMID: 8960431]
[http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a014806] [PMID: 8960431]
[20]
Nakamura M, Yoshida H, Naganuma Y, Kon H, Sugawara S, Hiramori K. Peripheral vasodilatory dysfunction in adult patients with congenital heart disease and severely elevated pulmonary vascular resistance. Angiology 2002; 53(6): 715-20.
[http://dx.doi.org/10.1177/000331970205300613] [PMID: 12463626]
[http://dx.doi.org/10.1177/000331970205300613] [PMID: 12463626]
[21]
Oechslin E, Kiowski W, Schindler R, Bernheim A, Julius B, Brunner-La RHP. Systemic endothelial dysfunction in adults with cyanotic congenital heart disease. Circulation 2005; 112(8): 1106-12.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.534073] [PMID: 16103236]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.534073] [PMID: 16103236]
[22]
Brili S, Tousoulis D, Antoniades C, et al. Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta. Atherosclerosis 2005; 182(1): 97-103.
[http://dx.doi.org/10.1016/j.atherosclerosis.2005.01.030] [PMID: 16115479]
[http://dx.doi.org/10.1016/j.atherosclerosis.2005.01.030] [PMID: 16115479]
[23]
Lee MGY, Hemmes RA, Mynard J, et al. Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta. Int J Cardiol 2017; 243: 185-90.
[http://dx.doi.org/10.1016/j.ijcard.2017.05.075] [PMID: 28545853]
[http://dx.doi.org/10.1016/j.ijcard.2017.05.075] [PMID: 28545853]
[24]
Cordina RL, Nakhla S, O’Meagher S, Leaney J, Graham S, Celermajer DS. Widespread endotheliopathy in adults with cyanotic congenital heart disease. Cardiol Young 2015; 25(3): 511-9.
[http://dx.doi.org/10.1017/S1047951114000262] [PMID: 24666694]
[http://dx.doi.org/10.1017/S1047951114000262] [PMID: 24666694]
[25]
Nozaki Y, Nakayama-Inaba K, Ishizu T, et al. Endothelial dysfunction of conduit arteries in patients with repaired coarctation of the aorta. Int Heart J 2018; 59(6): 1340-5.
[http://dx.doi.org/10.1536/ihj.17-564] [PMID: 30305581]
[http://dx.doi.org/10.1536/ihj.17-564] [PMID: 30305581]
[26]
Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med 2008; 102(12): 1791-6.
[http://dx.doi.org/10.1016/j.rmed.2008.06.014] [PMID: 18678478]
[http://dx.doi.org/10.1016/j.rmed.2008.06.014] [PMID: 18678478]
[27]
Sun HY, Stauffer KJ, Nourse SE, Vu C, Tierney SES. Peripheral endothelial function after arterial switch operation for d-looped transposition of the great arteries. Pediatr Cardiol 2017; 38(5): 1010-5.
[http://dx.doi.org/10.1007/s00246-017-1609-6] [PMID: 28345114]
[http://dx.doi.org/10.1007/s00246-017-1609-6] [PMID: 28345114]
[28]
Martins JD, Zachariah J, Selamet Tierney ES, et al. Impact of treatment modality on vascular function in coarctation of the aorta: The LOVE‐COARCT study. J Am Heart Assoc 2019; 8(7): e011536.
[http://dx.doi.org/10.1161/JAHA.118.011536] [PMID: 30929556]
[http://dx.doi.org/10.1161/JAHA.118.011536] [PMID: 30929556]
[29]
Radke RM, Diller G-P, Duck M, et al. Endothelial function in contemporary patients with repaired coarctation of aorta. Heart 2014; 100(21): 1696-701.
[http://dx.doi.org/10.1136/heartjnl-2014-305739] [PMID: 25095828]
[http://dx.doi.org/10.1136/heartjnl-2014-305739] [PMID: 25095828]
[30]
Weismann CG, Ljungberg S, Åkesson A, Hlebowicz J. Multimodal assessment of vascular and ventricular function in children and adults with bicuspid aortic valve disease. Front Cardiovasc Med 2021; 8: 643900.
[http://dx.doi.org/10.3389/fcvm.2021.643900] [PMID: 33834044]
[http://dx.doi.org/10.3389/fcvm.2021.643900] [PMID: 33834044]
[31]
Weismann CG, Maretic A, Grell BS, Åkesson A, Hlebowicz J, Liuba P. Multimodal assessment of vascular and ventricular function in children and adults with repaired aortic coarctation. Int J Cardiol 2021; 323: 47-53.
[http://dx.doi.org/10.1016/j.ijcard.2020.08.095] [PMID: 32889020]
[http://dx.doi.org/10.1016/j.ijcard.2020.08.095] [PMID: 32889020]
[32]
Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: Methodology and clinical applications. Br J Clin Pharmacol 2001; 52(6): 631-46.
[http://dx.doi.org/10.1046/j.0306-5251.2001.01495.x] [PMID: 11736874 ]
[http://dx.doi.org/10.1046/j.0306-5251.2001.01495.x] [PMID: 11736874 ]
[33]
Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25(5): 918-23.
[http://dx.doi.org/10.1161/01.HYP.25.5.918] [PMID: 7737727]
[http://dx.doi.org/10.1161/01.HYP.25.5.918] [PMID: 7737727]
[34]
Brili S, Tousoulis D, Antoniades C, et al. Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: A randomized cross-over study. J Am Coll Cardiol 2008; 51(7): 742-9.
[http://dx.doi.org/10.1016/j.jacc.2007.10.036] [PMID: 18279739]
[http://dx.doi.org/10.1016/j.jacc.2007.10.036] [PMID: 18279739]
[35]
Borges JP, Lopes GO, Verri V, et al. A novel effective method for the assessment of microvascular function in male patients with coronary artery disease: A pilot study using laser speckle contrast imaging. Braz J Med Biol Res 2016; 49(10): e5541.
[http://dx.doi.org/10.1590/1414-431x20165541] [PMID: 27599202]
[http://dx.doi.org/10.1590/1414-431x20165541] [PMID: 27599202]
[36]
Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. Arterioscler Thromb Vasc Biol 2003; 23(2): 168-75.
[http://dx.doi.org/10.1161/01.ATV.0000051384.43104.FC] [PMID: 12588755]
[http://dx.doi.org/10.1161/01.ATV.0000051384.43104.FC] [PMID: 12588755]
[37]
Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4(1): 302-12.
[http://dx.doi.org/10.2174/1874192401004010302] [PMID: 21339899]
[http://dx.doi.org/10.2174/1874192401004010302] [PMID: 21339899]
[38]
Cordina RL, Celermajer DS. Chronic cyanosis and vascular function: Implications for patients with cyanotic congenital heart disease. Cardiol Young 2010; 20(3): 242-53.
[http://dx.doi.org/10.1017/S1047951110000466] [PMID: 20416139]
[http://dx.doi.org/10.1017/S1047951110000466] [PMID: 20416139]
[39]
Cuypers J, Leirgul E, Larsen TH, Berg A, Omdal TR, Greve G. Assessment of vascular reactivity in the peripheral and coronary arteries by Cine 3T-magnetic resonance imaging in young normotensive adults after surgery for coarctation of the aorta. Pediatr Cardiol 2013; 34(3): 661-9.
[http://dx.doi.org/10.1007/s00246-012-0522-2] [PMID: 23064837]
[http://dx.doi.org/10.1007/s00246-012-0522-2] [PMID: 23064837]
[40]
Cuypers J, Leirgul E, Samnøy S, et al. Assessment of coronary flow reserve in the coronary sinus by cine 3T-magnetic resonance imaging in young adults after surgery for tetralogy of Fallot. Pediatr Cardiol 2012; 33(1): 65-74.
[http://dx.doi.org/10.1007/s00246-011-0091-9] [PMID: 21901644]
[http://dx.doi.org/10.1007/s00246-011-0091-9] [PMID: 21901644]
[41]
Ogunshola OO, Djonov V, Staudt R, Vogel J, Gassmann M. Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain. Am J Physiol Regul Integr Comp Physiol 2006; 290(3): R678-84.
[http://dx.doi.org/10.1152/ajpregu.00246.2005] [PMID: 16254128]
[http://dx.doi.org/10.1152/ajpregu.00246.2005] [PMID: 16254128]
[42]
Belhassen L, Pelle G, Sediame S, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress–mediated vasodilation. Blood 2001; 97(6): 1584-9.
[http://dx.doi.org/10.1182/blood.V97.6.1584] [PMID: 11238095]
[http://dx.doi.org/10.1182/blood.V97.6.1584] [PMID: 11238095]
[43]
Segers VFM, Brutsaert DL, De Keulenaer GW. Cardiac remodeling: Endothelial cells have more to say than just NO. Front Physiol 2018; 9: 382.
[http://dx.doi.org/10.3389/fphys.2018.00382] [PMID: 29695980]
[http://dx.doi.org/10.3389/fphys.2018.00382] [PMID: 29695980]
[44]
Goldstein BH, Sandelin AM, Golbus JR, et al. Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation. Congenit Heart Dis 2012; 7(3): 226-34.
[http://dx.doi.org/10.1111/j.1747-0803.2011.00605.x] [PMID: 22176653]
[http://dx.doi.org/10.1111/j.1747-0803.2011.00605.x] [PMID: 22176653]
[45]
Lantz M, Kostulas K, Settergren M, Sjöstrand C. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure. J Interv Cardiol 2017; 30(3): 242-8.
[http://dx.doi.org/10.1111/joic.12383] [PMID: 28439982]
[http://dx.doi.org/10.1111/joic.12383] [PMID: 28439982]
[46]
Kochummen E, Umpaichitra V, Marwa A, Joshi K, Chin VL, Perez-Colon S. Assessment of microvascular function in children and adolescents with diabetes and obesity. Int J Endocrinol Metab 2019; 18(1): e90094.
[http://dx.doi.org/10.5812/ijem.90094] [PMID: 32308696]
[http://dx.doi.org/10.5812/ijem.90094] [PMID: 32308696]
[47]
Hayden J, O’Donnell G, deLaunois I, O’Gorman C. Endothelial peripheral arterial tonometry (Endo-PAT 2000) use in paediatric patients: A systematic review. BMJ Open 2023; 13(1): e062098.
[http://dx.doi.org/10.1136/bmjopen-2022-062098] [PMID: 36657756]
[http://dx.doi.org/10.1136/bmjopen-2022-062098] [PMID: 36657756]
[48]
Hodges GJ, Klentrou P, Cheung SS, Falk B. Comparison of laser speckle contrast imaging and laser-doppler fluxmetry in boys and men. Microvasc Res 2020; 128: 103927.
[http://dx.doi.org/10.1016/j.mvr.2019.103927] [PMID: 31593712]
[http://dx.doi.org/10.1016/j.mvr.2019.103927] [PMID: 31593712]
